Episodes 1-15 of 15
CV Risk in Patients with Narcolepsy: See the Data
Medical Industry FeatureCV Risk in Patients with Narcolepsy: See the Data
Early Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care
Medical Industry FeatureEarly Alzheimer’s Disease Treatment: Assessing Patients and Coordinating Care
Advancements in Understanding ALS Treatment
Medical Industry FeatureAdvancements in Understanding ALS Treatment
Investigating a gMG Therapy, Part 2: The Secondary Endpoint Results, Including MG Symptoms PRO
Medical Industry FeatureInvestigating a gMG Therapy, Part 2: The Secondary Endpoint Results, Including MG Symptoms PRO
Investigating a gMG Therapy, Part 1: The MG-ADL Results
Medical Industry FeatureInvestigating a gMG Therapy, Part 1: The MG-ADL Results
From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Medical Industry FeatureFrom Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Investigating a gMG Therapy, Part 3: Results from the Extension Studies
Medical Industry FeatureInvestigating a gMG Therapy, Part 3: Results from the Extension Studies
Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Medical Industry FeatureUnraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Medical Industry FeatureImproving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
Medical Industry FeatureBeyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
The Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease
Medical Industry FeatureThe Time Is Now: Early Diagnosis and Intervention in Alzheimer’s Disease
Recognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers
Medical Industry FeatureRecognizing Agitation in Alzheimer’s Dementia: A Screening Tool for Caregivers
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Medical Industry FeatureManaging NF1 PN with this First and Only FDA-Approved Treatment Option
Hand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)
Medical Industry FeatureHand-in-Hand: Walking Patients Through Their Journey with a Therapy for Early Alzheimer’s Disease (AD)
Patient-Centric Care for Managing Certain Manifestations of VHL Disease
Medical Industry FeaturePatient-Centric Care for Managing Certain Manifestations of VHL Disease
